Solvay stock: JPMorgan cuts target for Solvay stock from EUR 30.00 to EUR 28.50

Published on 10/22/2026 at 18:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 2026 underlying net sales reached EUR 1.03 billion. Solvay stock costs EUR 23.54 on October 22, 2026, minus 0.17 percent versus Xetra close.

JPMorgan target cut confirmed

JPMorgan cut its Solvay target from EUR 30.00 to EUR 28.50 on October 20, 2026.
Preliminary third-quarter 2026 underlying net sales reached EUR 1.03 billion.
Solvay stock costs EUR 23.54 at Lang & Schwarz on October 22, 2026 at 6:21 p.m. CEST, minus 0.17 percent versus the Xetra close of EUR 23.58.
Solvay will publish its final third-quarter results on November 4, 2026.

Editorial-Fotografie eines Börsenhandelsraums mit Kursdiagrammen und dem Kürzel BEL 20 — Börsen-Editorial-Szene im Euronext Brussels Handelsraum mit BEL 20 Charts zeigt Solvay S.A. Aktie BE0003470755 gehandelt, Illustration mit AI erstellt.

Solvay (ISIN BE0003470755) reported preliminary underlying net sales of EUR 1.03 billion for the third quarter of 2026 on October 19, 2026, while Solvay updated its full-year outlook. On October 20, 2026, Investing.com reported that JPMorgan cut its price target from EUR 30.00 to EUR 28.50. At Lang & Schwarz, Solvay was trading at EUR 23.54 on October 22, 2026 at 6:21 p.m. CEST, minus 0.17 percent versus the Xetra close of EUR 23.58.

JPMorgan target remains above price

The revised JPMorgan target stands 21.08 percent above the Lang & Schwarz price. Investing.com also reported that KBC lowered its target from EUR 27.00 to EUR 23.00, placing the two cited targets on opposite sides of the current quotation.

Third-quarter figures set the tone

Solvay recorded underlying EBITDA of EUR 173.00 million and free cash flow to shareholders from continuing operations of EUR 54.00 million in the third quarter of 2026, according to the October 19 release. The company said the Middle East conflict reduced underlying EBITDA by EUR 25.00 million during the quarter, including EUR 15.00 million linked to the continued shutdown of the Peroxide plant at the Sadara complex in Saudi Arabia.

Stock sits above yearly low

The EUR 23.54 Lang & Schwarz price was EUR 0.96 above the 52-week low of EUR 22.58 and EUR 5.62 below the 52-week high of EUR 29.16, both as of October 22, 2026. The primary Euronext Brussels quotation closed at EUR 23.44 at 5:35 p.m. CEST, while Solvay's market capitalization was EUR 2.4 billion and volume reached 398,356 shares.

Guidance and reporting date

Solvay now expects underlying EBITDA of EUR 720.00 million to EUR 740.00 million for fiscal year 2026, compared with its former range of EUR 770.00 million to EUR 850.00 million. Free cash flow guidance is EUR 120.00 million to EUR 150.00 million, after EUR 90.00 million of transformation expenses. Final third-quarter results are scheduled for November 4, 2026, according to Solvay's release.

Comparison with peers

Solvay: minus 0.17 percent, market capitalization EUR 2.4 billion. BASF (Xetra, EUR): minus 0.40 percent, P/E 7.88, market capitalization EUR 45.2 billion. Arkema (Euronext Paris, EUR): minus 0.81 percent, P/E 342.81, market capitalization EUR 4.1 billion.

What the target cut means

The current quotation remains below JPMorgan's revised target but above KBC's EUR 23.00 target. The sharper issue for investors is the lower earnings range, which leaves the final November 4 report as the next dated test of Solvay's cash-generation outlook.

Solvay stock price and outlook

Solvay was trading at EUR 23.54 at Lang & Schwarz on October 22, 2026 at 6:21 p.m. CEST, minus 0.17 percent versus the Xetra close of October 22, 2026 at EUR 23.58. The further course of trading is shown by the continuously updated real-time quote of Solvay stock.